Novartis Aktie

Kaufen

Verkaufen

Novartis Aktien-Sparplan Novartis Aktien-Sparplan

129,12 EUR +1,52 EUR +1,19 %

12:31:57

STU

118,08 CHF +0,88 CHF +0,75 %

12:18:39

SWX

Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.233,58 Mrd. EUR

KGV18,30Div. Rendite3,38%

WKN904278

ISINCH0012005267

SymbolNVSEF

Novartis Aktien News

Sortieren:Datum Meistgelesen

13.05.26Zacks Implied Volatility Surging for Novartis Stock Options

07.05.26ZacksHere's Why Alcon (ALC) is a Strong Value Stock

07.05.26Dow JonesPress Release: Novartis breaks ground on Denton, -2-

WerbungNovartis-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

07.05.26Dow JonesPress Release: Novartis breaks ground on Denton, -2-

07.05.26Dow JonesPress Release: Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities

06.05.26MotleyFoolAlcon (ALC) Q1 2026 Earnings Call Transcript

06.05.26BenzingaAlcon Q1 2026 Earnings Call Transcript

30.04.26Dow JonesPress Release: Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

28.04.26ZacksNovartis Q1 Earnings & Revenues Miss Estimates, Stock Down

28.04.26ZacksNovartis (NVS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

28.04.26BenzingaNovartis CEO Flags Risks From Trump's MFN Drug Policy As Q1 Earnings Miss Estimates

28.04.26Business TimesNovartis misses Q1 profit estimates on steep generic erosion

28.04.26Dow JonesPress Release: Novartis delivered strong growth -4-

28.04.26Dow JonesPress Release: Novartis delivered strong growth -3-

28.04.26Dow JonesPress Release: Novartis delivered strong growth -2-

28.04.26Dow JonesPress Release: Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed

27.04.26Dow JonesPress Release: Novartis Rhapsido(R) -2-

27.04.26Dow JonesPress Release: Novartis Rhapsido(R) receivesEuropean Commissionapproval asfirstoral targeted treatment for chronic spontaneous urticaria

24.04.26Dow JonesPress Release: Novartis receives positive CHMP -2-

24.04.26Dow JonesPress Release: Novartis receives positive CHMP opinion for Itvisma(R) for spinal muscular atrophy (SMA)

24.04.26Dow JonesPress Release: Novartis malaria treatment -2-

24.04.26Dow JonesPress Release: Novartis malaria treatment Coartem(R) Baby receives WHO prequalification, paving way for greater access for newborns and young infants

24.04.26Dow JonesPress Release: Novartis malaria treatment -2-

24.04.26Dow JonesPress Release: Novartis malaria treatment Coartem(R) Baby receives WHO prequalification, paving way for greater access for newborns and young infants

23.04.26ZacksUnveiling Novartis (NVS) Q1 Outlook: Wall Street Estimates for Key Metrics

Novartis News

Novartis News: auf dieser Seite finden Sie alle Novartis News und Nachrichten zur Novartis Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novartis News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novartis News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.